Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchial Basal Cell Transplantation for Bronchiectasis
NCT02722642Phase 2Unknown
- Sponsor
- Regend Therapeutics
- Start
- Mar 2016
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in bronchiectasis, sponsored by Regend Therapeutics. Primary endpoint: CT imaging of dilated bronchi at 6 months. Status: unknown.
02
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT02722642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722642.